Last update 08 May 2025

Abbott Laboratories (Philippines), Inc.

Subsidiary Company|Philippines|
www.abbott.com.ph

Overview

Tags

Nervous System Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
μ opioid receptor(Mu opioid receptor)1

Related

94
Drugs associated with Abbott Laboratories (Philippines), Inc.
Remifentanil Hydrochloride
Target
μ opioid receptor
Mechanism
μ opioid receptor agonists
Active Org.
GSK PlcGSK Plc [+4]
Originator Org.
Abbott LaboratoriesAbbott Laboratories
Active Indication
Pain [+1]
Inactive Indication
Analgesia [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date12 Jul 1996
A-77636
Target
D1 receptor
Mechanism
D1 receptor agonists
Active Org.
The Ohio State UniversityThe Ohio State University [+2]
Originator Org.
Abbott Laboratories (Philippines), Inc.
Active Indication
Triple Negative Breast Cancer [+1]
Inactive Indication
Parkinson Disease
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
A-419259
Target
HCK x LCK
Mechanism
HCK inhibitors [+1]
Active Org.
Abbott LaboratoriesAbbott Laboratories
Originator Org.
Abbott Laboratories (Philippines), Inc.
Active Indication-
Inactive Indication
Myeloid Leukemia
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Abbott Laboratories (Philippines), Inc.
Login to view more data
0 Patents (Medical) associated with Abbott Laboratories (Philippines), Inc.
Login to view more data
100 Deals associated with Abbott Laboratories (Philippines), Inc.
Login to view more data
100 Translational Medicine associated with Abbott Laboratories (Philippines), Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
93
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Remifentanil Hydrochloride
 ( μ opioid receptor )		Anesthesia
More
Approved
A-77636
 ( D1 receptor )		Parkinson Disease
More
Discontinued
Amdoxovir
 ( RT )		HIV Infections
More
Discontinued
LG-370020
 ( IFN Receptors )		Inflammation
More
Discontinued
ABT-100
 ( FTase )		Solid tumor
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free